Comments
Ariad lung cancer drug shrinks tumors in small trial
30.09.2012. | (Reuters) - A small early-stage trial of Ariad Pharmaceuticals Inc's experimental pill AP26113 showed it shrank tumors in eight out of 11 lung cancer patients with a genetic mutation in a gene known as ALK....
